Armed-T | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

15,654 results for “Armed-T”

Trials

View all 7479 →

EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma

First posted Aug 13, 2015

T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System

6 participants · First posted Jan 25, 2016

Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated Glioblastoma

12 participants · First posted Jan 15, 2026

Drugs

View all 3505 →

HER2Bi-Armed T Cells

HER2Bi armed T cells(Shenzhen Beike Biotechnology)

CS1-dbBiTE armed T cells (City of Hope)

Organizations

View all 115 →

TAICHUNG ARMED FORCES GENERAL HOSPITAL

Taiwan

Armed Forces Hospital

Saudi Arabia

ARMED FORCES MEDICAL SERVICES

Saudi Arabia

News

View all 4555 →

UCLA's Dr. Theodore Scott Nowicki Receives $100,000 Hero Grant to Advance Armed CAR-T Therapy for Pediatric Osteosarcoma

SL Science Advances Allogeneic Gamma Delta T Cell Platform Toward IND, Reports 2025 Financial Results Following Nasdaq Listing

Elicera's iTANK-Armed CAR T-Cell Therapy Shows Complete Response in Lymphoma Patients

Page 1 of 1566